The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity - PubMed

Affiliations

• PMID: 16277612
• DOI: 10.1111/j.1471-4159.2005.03485.x

Free article

The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity

Analía Bortolozzi et al. J Neurochem. 2005 Dec.

Free article

Abstract

Atypical antipsychotics show preferential 5-HT 2A versus dopamine (DA) D2 receptor affinity. At clinical doses, they fully occupy cortical 5-HT2 receptors, which suggests a strong relationship with their therapeutic action. Half of the pyramidal neurones in the medial prefrontal cortex (mPFC) express 5-HT 2A receptors. Also, neurones excited through 5-HT 2A receptors project to the ventral tegmental area (VTA). We therefore hypothesized that prefrontal 5-HT 2A receptors can modulate DA transmission through excitatory mPFC-VTA inputs. In this study we used single unit recordings to examine the responses of DA neurones to local (in the mPFC) and systemic administration of the 5-HT 2A/2C agonist 1-[2,5-dimethoxy-4-iodophenyl-2-aminopropane] (DOI). Likewise, using microdialysis, we examined DA release in the mPFC and VTA (single/dual probe) in response to prefrontal and systemic drug administration. The local (in the mPFC) and systemic administration of DOI increased the firing rate and burst firing of DA neurones and DA release in the VTA and mPFC. The increase in VTA DA release was mimicked by the electrical stimulation of the mPFC. The effects of DOI were reversed by M100907 and ritanserin. These results indicate that the activity of VTA DA neurones is under the excitatory control of 5-HT 2A receptors in the mPFC. These observations may help in the understanding of the therapeutic action of atypical antipsychotics.

Similar articles

• In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.

  Bortolozzi A, Díaz-Mataix L, Toth M, Celada P, Artigas F. Bortolozzi A, et al. Psychopharmacology (Berl). 2007 Apr;191(3):745-58. doi: 10.1007/s00213-007-0698-y. Epub 2007 Jan 30. Psychopharmacology (Berl). 2007. PMID: 17265076

• Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.

  Mocci G, Jiménez-Sánchez L, Adell A, Cortés R, Artigas F. Mocci G, et al. Neuropharmacology. 2014 Apr;79:49-58. doi: 10.1016/j.neuropharm.2013.10.021. Epub 2013 Nov 7. Neuropharmacology. 2014. PMID: 24211653

• ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.

  Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY. Li Z, et al. Psychopharmacology (Berl). 2005 Dec;183(2):144-53. doi: 10.1007/s00213-005-0170-9. Epub 2005 Nov 9. Psychopharmacology (Berl). 2005. PMID: 16220333

• The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.

  Monti JM, Jantos H. Monti JM, et al. Prog Brain Res. 2008;172:625-46. doi: 10.1016/S0079-6123(08)00929-1. Prog Brain Res. 2008. PMID: 18772053 Review.

• Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs.

  Svensson TH. Svensson TH. Brain Res Brain Res Rev. 2000 Mar;31(2-3):320-9. doi: 10.1016/s0165-0173(99)00048-x. Brain Res Brain Res Rev. 2000. PMID: 10719159 Review.

Cited by

• Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.

  Higgins GA, Carroll NK, Brown M, MacMillan C, Silenieks LB, Thevarkunnel S, Izhakova J, Magomedova L, DeLannoy I, Sellers EM. Higgins GA, et al. Front Pharmacol. 2021 Feb 26;12:640241. doi: 10.3389/fphar.2021.640241. eCollection 2021. Front Pharmacol. 2021. PMID: 33716753 Free PMC article.

• Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT_2A receptor activation.

  Godar SC, Mosher LJ, Scheggi S, Devoto P, Moench KM, Strathman HJ, Jones CM, Frau R, Melis M, Gambarana C, Wilkinson B, DeMontis MG, Fowler SC, Coba MP, Wellman CL, Shih JC, Bortolato M. Godar SC, et al. Neuropharmacology. 2019 Nov 15;159:107513. doi: 10.1016/j.neuropharm.2019.01.028. Epub 2019 Feb 1. Neuropharmacology. 2019. PMID: 30716416 Free PMC article.

• Perturbed Developmental Serotonin Signaling Affects Prefrontal Catecholaminergic Innervation and Cortical Integrity.

  Garcia LP, Witteveen JS, Middelman A, van Hulten JA, Martens GJM, Homberg JR, Kolk SM. Garcia LP, et al. Mol Neurobiol. 2019 Feb;56(2):1405-1420. doi: 10.1007/s12035-018-1105-x. Epub 2018 Jun 9. Mol Neurobiol. 2019. PMID: 29948943 Free PMC article.

• Pharmacology of hallucinations: several mechanisms for one single symptom?

  Rolland B, Jardri R, Amad A, Thomas P, Cottencin O, Bordet R. Rolland B, et al. Biomed Res Int. 2014;2014:307106. doi: 10.1155/2014/307106. Epub 2014 Jun 4. Biomed Res Int. 2014. PMID: 24991548 Free PMC article. Review.

• Effects of the 5-HT_2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.

  Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J. Jaster AM, et al. Psychopharmacology (Berl). 2022 Jun;239(6):1665-1677. doi: 10.1007/s00213-022-06092-x. Epub 2022 Mar 2. Psychopharmacology (Berl). 2022. PMID: 35233648 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Digital CSIC Spanish National Research Council
  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database